1. Home
  2. ZNTL vs MAPS Comparison

ZNTL vs MAPS Comparison

Compare ZNTL & MAPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • MAPS
  • Stock Information
  • Founded
  • ZNTL 2014
  • MAPS 2008
  • Country
  • ZNTL United States
  • MAPS United States
  • Employees
  • ZNTL N/A
  • MAPS 457
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • MAPS Computer Software: Prepackaged Software
  • Sector
  • ZNTL Health Care
  • MAPS Technology
  • Exchange
  • ZNTL Nasdaq
  • MAPS Nasdaq
  • Market Cap
  • ZNTL 118.3M
  • MAPS 106.3M
  • IPO Year
  • ZNTL 2020
  • MAPS N/A
  • Fundamental
  • Price
  • ZNTL $1.35
  • MAPS $0.94
  • Analyst Decision
  • ZNTL Buy
  • MAPS Strong Buy
  • Analyst Count
  • ZNTL 6
  • MAPS 1
  • Target Price
  • ZNTL $6.53
  • MAPS $2.61
  • AVG Volume (30 Days)
  • ZNTL 772.7K
  • MAPS 933.2K
  • Earning Date
  • ZNTL 11-10-2025
  • MAPS 11-06-2025
  • Dividend Yield
  • ZNTL N/A
  • MAPS N/A
  • EPS Growth
  • ZNTL N/A
  • MAPS N/A
  • EPS
  • ZNTL N/A
  • MAPS 0.07
  • Revenue
  • ZNTL $26,865,000.00
  • MAPS $179,305,000.00
  • Revenue This Year
  • ZNTL N/A
  • MAPS N/A
  • Revenue Next Year
  • ZNTL N/A
  • MAPS $5.43
  • P/E Ratio
  • ZNTL N/A
  • MAPS $13.61
  • Revenue Growth
  • ZNTL N/A
  • MAPS N/A
  • 52 Week Low
  • ZNTL $1.01
  • MAPS $0.71
  • 52 Week High
  • ZNTL $4.44
  • MAPS $1.65
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 41.00
  • MAPS 37.11
  • Support Level
  • ZNTL $1.25
  • MAPS $0.89
  • Resistance Level
  • ZNTL $1.41
  • MAPS $1.04
  • Average True Range (ATR)
  • ZNTL 0.10
  • MAPS 0.06
  • MACD
  • ZNTL -0.02
  • MAPS -0.01
  • Stochastic Oscillator
  • ZNTL 23.71
  • MAPS 16.67

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About MAPS WM Technology Inc.

WM Technology Inc is a technology and software infrastructure provider to the cannabis industry. It comprises the B2C platform Weedmaps, and B2B software WM Business. Its revenues are derived primarily from monthly subscriptions to Weedmaps for Business, featured and deal listings and other WM Ad solutions. The Weedmaps for Business subscriptions generally have one-month terms that automatically renew unless notice of cancellation is provided in advance. Featured and deal listings and other WM Ad solutions are offered as add-on products to the Weedmaps for Business subscriptions. Featured and deal listings provide customers with premium placement ad solutions and discount and promotion pricing tools. Other WM Ad solutions include banner ads and promotion tiles on marketplace ads.

Share on Social Networks: